{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:48:24Z","timestamp":1784749704543,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012498","name":"Alzheimer Society Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014405","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jpsychires.2025.03.022","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T03:28:57Z","timestamp":1741922937000},"page":"204-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The effects of psychedelic-assisted therapy on illness and death anxiety: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-2261","authenticated-orcid":false,"given":"Aron","family":"Amaev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-1692","authenticated-orcid":false,"given":"Yasaman","family":"Kambari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Carmona-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-4141","authenticated-orcid":false,"given":"Ali","family":"Abdolizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-5672","authenticated-orcid":false,"given":"Fumihiko","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio P.","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ishrat","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2025.03.022_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpsychores.2018.10.002","article-title":"Death anxiety and its association with hypochondriasis and medically unexplained symptoms: a systematic review","volume":"115","author":"aan de Stegge","year":"2018","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cncr.35010","article-title":"Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder","volume":"130","author":"Agrawal","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"issue":"100538","key":"10.1016\/j.jpsychires.2025.03.022_bib5","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12904-017-0245-5","article-title":"\u2018Worried to death\u2019: the assessment and management of anxiety in patients with advanced life-limiting disease, a national survey of palliative medicine physicians","volume":"16","author":"Atkin","year":"2017","journal-title":"BMC Palliat. Care"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10615806.2015.1036243","article-title":"Health anxiety and hypochondriasis in the light of DSM-5","volume":"29","author":"Bailer","year":"2016","journal-title":"Anxiety Stress Coping"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00005650-200107000-00007","article-title":"Resource utilization of patients with hypochondriacal health anxiety and somatization","volume":"39","author":"Barsky","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib9","first-page":"71","article-title":"The cost of somatisation among the working\u2010age population in England for the year 2008\u20132009","volume":"7","author":"Bermingham","year":"2010","journal-title":"Ment. Health Fam. Med."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004596.pub2","article-title":"Drug therapy for symptoms associated with anxiety in adult palliative care patients","author":"Candy","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic Brain: toward a unified model of the Brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/16506073.2023.2166578","article-title":"Psychological treatment of depression with other comorbid mental disorders: systematic review and meta-analysis","volume":"52","author":"Cuijpers","year":"2023","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib17","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","article-title":"Chapter 10: chapter 10: analysing data and undertaking meta-analyses [last updated November 2024]","author":"Deeks","year":"2024"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/JCP.0000000000001428","article-title":"Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial","volume":"41","author":"Dos Santos","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.03.022_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17470910802649470","article-title":"Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration","volume":"4","author":"Dumont","year":"2009","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S0033291708003322","article-title":"A taxometric analysis of health anxiety","volume":"39","author":"Ferguson","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2022.152334","article-title":"Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: implications for trial design","volume":"118","author":"Fineberg","year":"2022","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib24","series-title":"StatPearls","article-title":"Illness anxiety disorder","author":"French","year":"2022"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1891\/0889-8391.22.2.167","article-title":"Death anxiety: a cognitive-behavioral approach","volume":"22","author":"Furer","year":"2008","journal-title":"J. Cognit. Psychother."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12874-021-01310-0","article-title":"Most published meta-regression analyses based on aggregate data suffer from methodological pitfalls: a meta-epidemiological study","volume":"21","author":"Geissb\u00fchler","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2190\/0DQB-7Q1E-2BER-H6YC","article-title":"Death attitudes across the life-span: the development and validation of the death attitude profile (DAP)","volume":"18","author":"Gesser","year":"1988","journal-title":"Omega (Westport)"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.03.022_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0269216317722123","article-title":"Death anxiety interventions in patients with advanced cancer: a systematic review","volume":"32","author":"Grossman","year":"2018","journal-title":"Palliat. Med."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115531","article-title":"Psilocybin-assisted therapy for depression: a systematic review and meta-analysis","volume":"329","author":"Haikazian","year":"2023","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.03.022_bib34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall","year":"2006","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.03.022_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/13674670412331304311","article-title":"The influence of religion on death anxiety and death acceptance","volume":"8","author":"Harding","year":"2005","journal-title":"Ment. Health Relig. Cult."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib36","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane bias methods group, & Cochrane statistical methods group. The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib37","first-page":"215","article-title":"Lysergic acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biological Psychiatry, Clinical and Neural Phenotypes of Depression"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1076459","article-title":"Serotonergic psychedelics for depression: what do we know about neurobiological mechanisms of action?","volume":"13","author":"Husain","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cpr.2014.09.002","article-title":"Death anxiety and its role in psychopathology: reviewing the status of a transdiagnostic construct","volume":"34","author":"Iverach","year":"2014","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jpainsymman.2017.06.010","article-title":"Safety and effectiveness of palliative drug treatment in the last days of life\u2014a systematic literature review","volume":"55","author":"Jansen","year":"2018","journal-title":"J. Pain Symptom Manag."},{"issue":"7","key":"10.1016\/j.jpsychires.2025.03.022_bib41","first-page":"917","article-title":"The pharmacology and toxicology of \u201cecstasy\u201d (MDMA) and related drugs","volume":"165","author":"Kalant","year":"2001","journal-title":"CMAJ: Can. Med. Assoc. J."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234124","article-title":"Health anxiety and illness-related fears across diverse chronic illnesses: a systematic review on conceptualization, measurement, prevalence, course, and correlates","volume":"15","author":"Lebel","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/02698811211044688","article-title":"Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: a systematic review and meta-analysis","volume":"36","author":"Leger","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.03.022_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","article-title":"Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) are attenuated by the serotonin uptake inhibitor citalopram","volume":"22","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebr.2021.100469","article-title":"Remote delivery of cognitive behavioral therapy to patients with functional neurological disorders: promise and challenges","volume":"16","author":"Lin","year":"2021","journal-title":"Epilepsy & Behavior Reports"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib46","article-title":"Bias caused by sampling error in meta-analysis with small sample sizes","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib47","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3390\/molecules26102948","article-title":"The therapeutic potential of psilocybin","volume":"26","author":"Lowe","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.03.022_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/02791072.2020.1769878","article-title":"A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy","volume":"52","author":"Luoma","year":"2020","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.644932","article-title":"Fear of cancer recurrence, health anxiety, worry, and uncertainty: a scoping review about their conceptualization and measurement within breast cancer survivorship research","volume":"12","author":"Maheu","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1037\/abn0000577","article-title":"The effect of mortality salience on bodily scanning behaviors in anxiety-related disorders","volume":"130","author":"Menzies","year":"2021","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.janxdis.2018.09.004","article-title":"The effects of psychosocial interventions on death anxiety: a meta-analysis and systematic review of randomised controlled trials","volume":"59","author":"Menzies","year":"2018","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib52","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","article-title":"Blinding and expectancy confounds in psychedelic randomized controlled trials","volume":"14","author":"Muthukumaraswamy","year":"2021","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychores.2017.07.010","article-title":"DSM-5 illness anxiety disorder and somatic symptom disorder: comorbidity, correlates, and overlap with DSM-IV hypochondriasis","volume":"101","author":"Newby","year":"2017","journal-title":"J. Psychosom. Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.03.022_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/02791072.1986.10472362","article-title":"Differences between the mechanism of action of MDMA, MBDB, and the classic Hallucinogens. Identification of a new therapeutic class: entactogens","volume":"18","author":"Nichols","year":"1986","journal-title":"J. Psychoact. Drugs"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.03.022_bib55","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00482-012-1241-6","article-title":"[Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses : a systematic review]","volume":"26","author":"N\u00fcbling","year":"2012","journal-title":"Schmerz"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib57","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 13: assessing risk of bias due to missing evidence in a meta-analysis","author":"Page","year":"2024"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.euroneuro.2023.07.011","article-title":"Psilocybin-assisted therapy for depression: a systematic review and dose-response meta-analysis of human studies","volume":"76","author":"Perez","year":"2023","journal-title":"Eur. Neuropsychopharmacol. : the journal of the European College of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.03.022_bib59","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/pon.5030","article-title":"Characterizing death acceptance among patients with cancer","volume":"28","author":"Philipp","year":"2019","journal-title":"Psychooncology"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.03.022_bib60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2190\/MHEL-88YD-UHKF-E98C","article-title":"Death anxiety and death acceptance: a preliminary approach","volume":"5","author":"Ray","year":"1975","journal-title":"Omega: J. Death Dying"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib61","series-title":"The Life Attitude Profile-Revised:(LAP-R). Peterborough, Ontario, Canada: Student Psychologists Press","author":"Reker","year":"2001"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib62","series-title":"Review Manager 5 (RevMan 5) [Computer Program]. Version 5.4","year":"2020"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib63","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib64","first-page":"CD004596","article-title":"Drug therapy for symptoms associated with anxiety in adult palliative care patients","volume":"5","author":"Salt","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/PSY.0000000000000691","article-title":"Illness anxiety disorder: psychopathology, epidemiology, clinical characteristics, and treatment","volume":"81","author":"Scarella","year":"2019","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-021-06027-y","article-title":"Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review","volume":"239","author":"Schimmel","year":"2022","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.jpsychires.2025.03.022_bib67","first-page":"CD015383","article-title":"Psychedelic\u2010assisted therapy for treating anxiety, depression, and existential distress in people with life\u2010threatening diseases","author":"Schipper","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7653","key":"10.1016\/j.jpsychires.2025.03.022_bib68","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib70","series-title":"Encyclopedia of Quality of Life and Well-Being Research","first-page":"6261","article-title":"Spielberger state-trait anxiety inventory","author":"Skapinakis","year":"2014"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.03.022_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jnc.15540","article-title":"Molecular insights into psychedelic drug action","volume":"162","author":"Slocum","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib72","series-title":"State-Trait Anxiety Inventory For Adults (STAI-AD) [Database Record]","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1017\/S1478951513000199","article-title":"Perceptions of two therapeutic approaches for palliative care patients experiencing death anxiety","volume":"12","author":"Sussman","year":"2014","journal-title":"Palliat. Support Care"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00221309.1970.9920634","article-title":"The construction and validation of a death anxiety scale","volume":"82","author":"Templer","year":"1970","journal-title":"J. Gen. Psychol."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib76","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(13)61905-4","article-title":"Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial","volume":"383","author":"Tyrer","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib77","series-title":"The Clinician's Guide to Treating Health Anxiety","first-page":"35","article-title":"Chapter three - etiology and epidemiology of health anxiety","author":"Tyrer","year":"2019"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib78","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14740338.2022.2047929","article-title":"The therapeutic potential of psilocybin: a systematic review","volume":"21","author":"van Amsterdam","year":"2022","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.jpsychires.2025.03.022_bib79","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231198466","article-title":"History repeating: guidelines to address common problems in psychedelic science","volume":"13","author":"van Elk","year":"2023","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I2 can be biased in small meta-analyses","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.03.022_bib81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.npp.1395197","article-title":"Psychological and cardiovascular effects and short-term sequelae of MDMA (\u201cEcstasy\u201d) in MDMA-naive healthy volunteers","volume":"19","author":"Vollenweider","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1016\/j.jpsychires.2025.03.022_bib82","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpsychires.2025.03.022_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75706-1","article-title":"MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study","volume":"10","author":"Wolfson","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625001761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625001761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:37:11Z","timestamp":1762209431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625001761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":80,"alternative-id":["S0022395625001761"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.03.022","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of psychedelic-assisted therapy on illness and death anxiety: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}